Carnegie Investment Counsel’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,250
| Closed | -$63K | – | 489 |
|
|
2022
Q2 | $63K | Sell |
14,250
-21,500
| -60% | -$95.1K | ﹤0.01% | 464 |
|
|
2022
Q1 | $325K | Sell |
35,750
-4,922
| -12% | -$44.7K | 0.01% | 402 |
|
|
2021
Q4 | $832K | Sell |
40,672
-3,300
| -8% | -$67.5K | 0.03% | 289 |
|
|
2021
Q3 | $1.12M | Buy |
43,972
+1,950
| +5% | +$49.8K | 0.04% | 234 |
|
|
2021
Q2 | $1.47M | Buy |
42,022
+6,600
| +19% | +$231K | 0.06% | 221 |
|
|
2021
Q1 | $1.18M | Buy |
35,422
+6,122
| +21% | +$204K | 0.05% | 232 |
|
|
2020
Q4 | $760K | Buy |
+29,300
| New | +$760K | 0.03% | 250 |
|